16 Best Consumer Products M&A Advisors: Food, Beverage & Beauty in 2026

16 Best Consumer Products M&A Advisors: Food, Beverage & Beauty in 2026

Last updated: September 2026 · Last verified: September 2026

TL;DR. Consumer is not one M&A market. It is a Three-Speed Consumer Market — mega-cap portfolio surgery at the top, a $500M-$2B growth-brand takeout class in the middle, and a velocity-priced lower middle market underneath — and the speed you are in decides the adviser you need. The 2025 consumer median was 9.2x EV/EBITDA, a 10-year low against a 10.5x 2016-2025 median, with volume down 18.9% (Capstone Partners Annual Consumer M&A Report, April 2026); beauty ran 14.9x (Capstone Partners Beauty M&A Update, December 2025) and snacks 16.9x. The inversion nobody prices in: sponsors paid 10.4x against strategics' 8.6x in 2025 (Capstone Partners, April 2026). I ranked this bench on one standard — a dated adviser-of-record credit in a primary source. Piper Sandler and Centerview Partners sold Simple Mills at $795M on $240M of 2024 net sales (Flowers Foods 8-K, January 2025); Whipstitch Capital sold Copra to Vita Coco for $175M upfront opposite Evercore (Vita Coco 8-K, July 2026). Also ranked: William Blair, Goldman Sachs, J.P. Morgan, Lazard, Harris Williams, Solomon Partners, Intrepid Investment Bankers, CG Sawaya Partners, Lincoln International, Houlihan Lokey, Robert W. Baird, Arlington Capital Advisors and Cascadia Capital. I run Peony, a data room company used by 6,800+ customers — we are not an advisor, we are the confidential room the process runs in.

By the numbers

• 9.2x median consumer EV/EBITDA in 2025, a 10-year low, versus 9.6x in 2024 and a 10.5x 2016-2025 median; deal volume fell 18.9% (Capstone Partners Annual Consumer M&A Report, April 2026).
• 10.4x versus 8.6x — the median multiple paid by private equity against the median paid by strategics in 2025. Sponsors outbid strategics by 1.8 turns, our arithmetic on Capstone's two medians (Capstone Partners, April 2026).
• 11.6x versus 7.6x — branded processed foods against private-label food public comps, four full turns for the brand, with snacks the premium pocket at 16.9x (Capstone Partners Food M&A Update, April 2026).
• 14.9x average beauty EV/EBITDA in YTD 2025, more than five turns above the 9.8x consumer average (Capstone Partners Beauty M&A Update, December 2025).
• $93.2M — Goldman Sachs' fee on the $35.9B Mars/Kellanova deal, against up to $22M on the $3.1B Ferrero/WK Kellogg deal: 0.26% versus 0.71% of enterprise value, our arithmetic on the two proxies (Kellanova DEFM14A, September 2024; WK Kellogg DEFM14A, August 2025).
• 43.2% of Celsius Holdings' FY2025 revenue came from Pepsi, and 10.8% from Costco (Celsius 10-K, March 2026); the $133.9M Hart-Scott-Rodino floor took effect February 17, 2026 (91 FR 2133).
• 39% of US private-equity portfolio companies had been held more than four years at the end of 2025; at 2025's exit pace of 972, clearing that backlog would take more than seven years (Capstone Partners, April 2026).

Why I wrote this — and why "consumer" is not one market

I'm Sean Yu, co-founder of Peony, a data room company used by 6,800+ customers. I work on the layer that decides who — and now what — is allowed to read a confidential document, which puts me on the document side of a lot of consumer deals. This guide is for the founder-CEO of a branded consumer company doing roughly $60M in net revenue, growing about 25%, with around $8M of adjusted EBITDA after trade spend, one primary co-manufacturer, and unsolicited inbound from a strategic in the same aisle.

A consumer products M&A advisor is an investment bank or advisory firm that runs the sale, recapitalization or capital raise of a branded consumer business — food, beverage, beauty and personal care, household, pet — on the owner's behalf. The job: build the buyer list, write the confidential information memorandum, normalize trade-spend-burdened earnings into a defensible EBITDA, run competitive tension between strategics and sponsors, negotiate structure. Most operate through a registered broker-dealer; some under the federal M&A-broker exemption. For the label distinctions see M&A advisor vs broker vs investment bank, and for the cross-sector view our best M&A advisors hub.

Most lists in this category name twelve firms and cite nothing. So I built this one against one standard, the Adviser-of-Record Ledger, a Peony-original evidence standard: a firm earns a rank only if I could find a dated 2024-2026 consumer adviser-of-record credit in a primary source — an SEC filing, a counterparty's press release, or the firm's own dated tombstone. Where evidence is thin I say so inside the profile rather than padding the count.

Those lists also miss that consumer is not one market. It runs at three speeds at once, with different buyers, multiples and advisers in each, and a founder reading the wrong lane's data will misprice their company by turns. That is the Three-Speed Consumer Market frame this guide is built on.

Peony is not an M&A advisor and does not place deals — the firms below do that. Peony is the confidential room a sale runs in: pick your advisor first, then stand up the room. Buyers should start with how to acquire a company; founders still raising want the CPG fundraising data room guide.

Which advisors actually sold the consumer brands that changed hands in 2025 and 2026?

A small, repeating set of firms did, and you can name most of them from SEC filings alone. Below is the Adviser-of-Record Ledger: every 2024-2026 consumer transaction where I could read the adviser roster in a primary document, with the value exactly as the cited source states it.

Bottom line: fourteen deals, and the sell-side roster is only thirteen firms deep — Goldman, J.P. Morgan, Centerview, Lazard, Morgan Stanley, BofA, Moelis, Citi, RBC, Piper Sandler, CG Sawaya, Houlihan Lokey and Whipstitch.

Now the honest part: most consumer deals disclose no bankers at all. For Touchland, Dr. Squatch, LesserEvil, Medik8, Kering Beauté, Grüns, Huel, Thorne and Purely Elizabeth, no financial adviser was named in any primary source I could reach. On rhode, e.l.f. Beauty named only Latham & Watkins as legal counsel and no bank at all on the buy side. Private buyers and sellers need not publish a roster, and most don't.

Two consequences. Any list claiming a firm "advised on" a private consumer deal without a filing, a tombstone or a party's own release behind it is asserting, not reporting. And because the record is patchy by construction, you cannot shop on reputation alone — ask each firm for references on deals it cannot publish, then call them. Once your process is live, page-level analytics on your own room tell you more about who is genuinely engaged than any league table will.

What is the three-speed consumer market — and which lane is your brand in?

Consumer M&A ran at three speeds in 2025-26 that barely touched each other. I call it the Three-Speed Consumer Market, a Peony-original frame, because the top and bottom do opposite things while a hot middle lane sits between them: mega-caps subtracting, growth-brand buyers adding at premium prices, and a lower middle market priced off shelf velocity rather than narrative.

Lane A: mega-cap portfolio surgery, $2B and up

The largest deals of this cycle were breakups, category exits and one transformational merger, not growth-buying. Kimberly-Clark agreed to acquire Kenvue at approximately $48.7B of enterprise value when announced in November 2025 — about 14.3x Kenvue's LTM adjusted EBITDA, or 8.8x including $2.1B of expected run-rate synergies. It has not closed. Both shareholder bases approved in January 2026; Kimberly-Clark's CEO said on August 4, 2026 that it "remains on track to close by the end of this year"; Australia's regulator cleared it on September 2, 2026 subject to divesting Carefree and Stayfree, and China's SAMR moved it into an in-depth review. Mars closed Kellanova at about $35.9B in December 2025. Keurig Dr Pepper closed JDE Peet's on April 1, 2026, expressly to split itself in two afterwards. McCormick agreed in March 2026 to combine with Unilever's Foods business at $44.8B of enterprise value, 3.6x revenue and 13.8x EBITDA (Capstone Partners Food M&A Update, April 2026), still pending.

The subtraction side is as busy. Kraft Heinz paused its own two-company split on February 11, 2026 — not pending, on hold. Unilever completed its ice-cream demerger on December 8, 2025. Reckitt confirmed completion of the $4.8B Essential Home sale to Advent International on December 31, 2025. Nestlé created the Peranel water joint venture with Platinum Equity in July 2026 and agreed on September 1, 2026 to sell seven mainstream vitamin brands to Yellow Wood Partners for $1B. None of this is a market for your $60M brand. It is the market that creates the divested assets your competitors buy.

Lane B: the $500M-$2B growth-brand takeout class

The live, banker-intensive lane, and where consumer M&A actually gets priced:

• Flowers Foods paid $795M for Simple Mills against $240M of 2024 net sales — 3.3x revenue — printing both numbers in the same release. The cleanest published multiple on the tape.
• Celsius paid a net $1.65B for Alani Nu, describing it as less than 3x 2024A net revenue and approximately 12x fully synergized 2024A EBITDA. Capstone's table puts the same deal at a $1,885.8M enterprise value, 3.2x revenue and 13.8x EBITDA (Capstone Partners Beverage Sector M&A Update, March 2026) — two numerators, so attribute whichever you quote.
• e.l.f. Beauty's "$1 billion" rhode deal was $800M at closing plus up to $200M of earnout, its 10-Q booking $897.5M against roughly $212M of net sales — about 3.8x revenue on the closing figure. The $7.1M earnout carrying value against a $200M cap is the lesson: an earnout is worth what its terms make probable. See how to structure an earnout.
• Church & Dwight paid $700M at close for Touchland plus up to $180M of earn-out; Latham & Watkins framed it as US$880 million. No published revenue denominator, so no revenue multiple.
• Unilever agreed in June 2025 to buy Dr. Squatch from Summit Partners at a reported ~$1.5B (Financial Times); Unilever's release states no price — the deal completed later in 2025. Hershey bought LesserEvil at $750M (Wall Street Journal, April 2025), closing November 19, 2025. PepsiCo closed poppi on May 19, 2025 at $1.95B including about $300M of anticipated tax benefits, and Siete Foods at $1.2B on January 17, 2025. None published a revenue base.
• 2026 kept it open: Unilever agreed to buy Grüns at a reported $1.2B in April 2026; Danone agreed to buy Huel at about €1B, cleared by the UK Competition and Markets Authority on August 21, 2026; P&G agreed on August 4, 2026 to buy Thorne from L Catterton for $3.8B, pending; Ferrero agreed to buy Purely Elizabeth on August 14, 2026 at a reported $800M to $850M — Ferrero did not disclose terms.

Do not use poppi as your success story. Beverage-Digest reported on August 5, 2026 that poppi's sales fell in 2026.

Lane C: the velocity-priced lower middle market

Below roughly $500M, brands are priced off shelf performance and earnings quality. At the bottom of the market ($1M-$5M of EBITDA), Windsor Drake's Lower Mid-Market Valuation EBITDA Multiples 2025 — the latest edition published, and the only lower-middle-market CPG size-band benchmark I could find — puts branded CPG food and beverage at 6.8x at $1M-$3M of EBITDA and 8.1x at $3M-$5M. Auxo Capital Advisors' Food & Beverage Valuation Multiples 2026 Guide, updated July 6, 2026, publishes subcategory ranges of roughly 6.0x to 12.0x — functional and non-alcoholic beverages 8.0x-12.0x, ingredients and specialty food platforms 7.0x-11.0x, snacks and center-store brands 7.0x-10.0x, food manufacturing and co-manufacturing 6.5x-10.5x, foodservice and distribution 6.0x-9.0x. Auxo cites no external source; read it as an adviser's directional view.

Real 2026 transactions here: Vita Coco bought Copra for $175M upfront plus a $45M-floor, $100M-cap earnout; ETi Gıda bought TRUBAR for $173M cash in February 2026; Henkel agreed in March 2026 to buy Not Your Mother's from Main Post Partners, completing in April; Bansk Group agreed in March 2026 to buy a majority of So Good So You from Prelude Growth Partners. Sponsor exits and cross-border strategics, at modest or undisclosed prices, with earnouts.

The reprice signal came from a buyer. Mondelēz's chief executive said in March 2026 that M&A had become harder because targets were "too expensive" (Food Dive, March 2026) — while PepsiCo, Unilever, P&G, Ferrero, Hershey and Danone each agreed to pay $750M to $3.8B for a single growth brand in the same window.

So which lane are you in? At roughly $60M of net revenue, 25% growth and $8M of adjusted EBITDA, you sit at the top of Lane C and the bottom of Lane B, and your adviser's job is to move you across that line. If growth is durable, gross margin survives a trade-spend rebuild, and you are in the better-for-you or functional-beverage pocket, you are a Lane B conversation and want a bank whose buyer list includes the strategics that bought Simple Mills, Alani Nu and Copra. If growth has decelerated, margin is promotion-dependent, or one retailer carries the brand, you are a Lane C conversation priced off velocity and earnings quality. Still deciding? Read how to sell a food and beverage brand or how to sell a beauty brand first.

What are consumer brands actually selling for in 2026?

Less than last cycle, and far less evenly. The consumer industry median was 9.2x EV/EBITDA in 2025 — a 10-year low — against 9.6x in 2024 and a 10.5x median across 2016-2025, with volume down 18.9% and large deals above $250M taking a record 30.6% of disclosed transactions (Capstone Partners Annual Consumer M&A Report, April 27, 2026). That is the market's centre of gravity, not a quote for a branded, fast-growing asset.

Food shows the recovery. Average food EBITDA multiples ran 15.4x in 2023, 14.9x in 2024, 12.3x in 2025 and 12.7x in YTD 2026 (Capstone Partners Food M&A Update, April 30, 2026). Volume rebounded 66.7% year over year in early 2026 and branded food deals more than tripled, up 210%, to 77.5% of volume. Inside food, the segment spread is the story:

Public company data by segment, LTM as of March 3, 2026 (Capstone Partners Food M&A Update, April 2026).

Bottom line: branded beats private label by four full turns, and the oddity is that better-for-you public comps trade at only 8.1x even though better-for-you targets were 69.2% of strategic and 85.7% of private-equity food acquisitions in YTD 2026. Private demand runs far ahead of the public trading multiple — the arbitrage a strategic monetizes paying 3x-4x revenue for a growth brand.

Beyond food: beverage averaged 12.2x across 2024-2025, with non-alcoholic public comps at 13.2x against alcoholic at 9.3x, on 178 deals in 2025, down 18.3% (Capstone Partners Beverage Sector M&A Update, March 17, 2026). Beauty averaged 14.9x in YTD 2025 against a 9.8x consumer average — five turns of premium — across 56 deals, down only 6.7% while the industry fell 24.2% (Capstone Partners Beauty M&A Update, December 4, 2025). Pet is the one category I cannot give you a current number for honestly: Capstone's Pet Sector M&A Update, October 2025 edition, reported a 14.5x average across 2022-YTD, more than a turn above its 2018-2021 range, and the current April 2026 edition publishes no multiple at all.

A category median is a starting point, never a quote. It averages every size, growth rate and margin profile in the category; your brand has one of each. An adviser leading with a median instead of a comparable set is selling you the market, not your company.

Who is buying consumer brands in 2026 — and why did sponsors outbid strategics?

Strategics do most of the volume, but in 2025 private equity paid the higher median multiple — 10.4x against 8.6x for strategic buyers (Capstone Partners Annual Consumer M&A Report, April 2026). A 1.8-turn inversion on our arithmetic, and it reverses the line every seller has been told. Call it the Sponsor Premium Inversion, a Peony-original frame.

Capstone's explanation is about pressure, not enthusiasm. Sponsors faced elevated limited-partner pressure to meet capital deployment mandates and competed harder for a narrower set of safe growth assets. Strategics self-selected into lower-multiple deals because of competing capital uses — artificial-intelligence integration and internal cost mitigation among them — and sensitivity about realizing synergies. Strategics can still pay the most for the right asset; the median sponsor deal simply cleared 1.8 turns above the median strategic deal. Which is a room-design problem before it is a banker problem: a buyer list that is a third sponsors means a third of your readers need their own tranche, their own Q&A thread and their own watermark.

Consumer is markedly less strategic-tilted than building products — food is only 65% strategic against building products' 87.5%, a 22.5-point gap (see our building products M&A advisors guide). A strategics-only process ignores roughly a third of the buyer universe, and the third that paid the higher median.

Beauty's mix moved violently. Public strategic buyers averaged 29.1% of beauty deal volume from 2018 to 2023, collapsed to 9% in 2024, and recovered to 16.1% in YTD 2025 — the corporate buyer left the room and is coming back, which matters for timing an indie beauty exit.

Sponsors have the mandate and the money. 39% of US private-equity portfolio companies had been held more than four years at the end of 2025, and at 2025's pace of 972 exits the backlog would take more than seven years to clear. Consumer dry powder kept arriving: VMG Partners closed Consumer Fund VI at $1.0B on May 13, 2025; Bansk Group closed Fund II at $1.45B on January 12, 2026, above a $1.0B target; CAVU Consumer Partners closed Fund V at $325M on February 3, 2026; Forward Consumer Partners closed Fund II at $500M on March 28, 2026; and L Catterton launched — launched, not closed — a $500M athlete-led "Champ" fund in April 2026. The counter-signal: Eurazeo shut down its brand investment arm in January 2026. Capital is concentrating into a smaller set of specialists. For the buy side see our consumer investors directory, the independent sponsor consumer capital partners guide and our private equity page; if you are raising, start at fundraising.

Strategics run portfolio surgery on both sides of the ledger at once. Unilever bought Dr. Squatch and Grüns while exiting Foods. PepsiCo bought poppi and sold Rockstar to Celsius. AB InBev bought BeatBox Beverages for $576.5M in November 2025 and sold its New York City distribution to Southern Glazer's. L'Oréal did six buy-side deals globally in 2025 and one divestment. Every divestiture becomes someone else's platform — which is why sponsor demand and strategic simplification are one story told from two ends.

And a brand does not have to be for sale to be bid for. Brown-Forman rejected a reported approach from Sazerac valued at roughly $15B three separate times between May and September 2026.

Bulge bracket, mid-market platform or category boutique — which tier fits a $60M brand?

Tier follows enterprise value and buyer universe, not prestige. For a $60M-revenue, $8M-EBITDA branded consumer company: above roughly $1B of enterprise value, a large-cap bank — Goldman Sachs, J.P. Morgan, Centerview, Lazard, Morgan Stanley — where buyer access and the ability to run a mega-cap counterparty are worth the fee. Between roughly $150M and $1B, a mid-market platform with a named consumer group: Piper Sandler, William Blair, Harris Williams, Solomon Partners, Lincoln International, Houlihan Lokey, Robert W. Baird, Intrepid, CG Sawaya. Between roughly $50M and $500M with a specific category — better-for-you food, beverage distribution, indie beauty, drinkware — a category boutique with live relationships in that aisle usually beats a bigger logo: Whipstitch Capital, Arlington Capital Advisors, Cascadia Capital. If growth has stalled and the buyer universe is two or three strategics you already know, the honest answer may be a direct negotiation with counsel and a quality-of-earnings provider — but read the fee arithmetic first.

Is $8M of adjusted EBITDA too small for a bulge-bracket bank to take seriously?

Usually yes, and the reason is fee economics rather than snobbery. On a $3.1B deal Goldman Sachs' contingent fee was $18M-$20M plus $2M on signing — up to $22M, about 0.71% of enterprise value on our arithmetic from the WK Kellogg proxy; on a $35.9B deal it was $93.2M, about 0.26%. Scale that curve to a $70M-$90M enterprise value and the absolute fee is smaller than the cost of staffing the process properly. A large-cap bank's edge is counterparty access at the top of the market; a boutique's edge is knowing which category manager at which strategic is hunting your subsegment this quarter. At $60M of revenue the second is worth more.

Who owns your adviser changes the conflict surface. Several strong consumer benches sit inside larger institutions: Harris Williams is PNC-owned; Capstone Capital Markets LLC is a subsidiary of Huntington Bancshares; Intrepid has been MUFG-owned since January 2019; CG Sawaya Partners sits inside Canaccord Genuity, which acquired Sawaya in December 2021; and CLA Meridian Capital is part of CliftonLarsonAllen. None of that disqualifies anyone. But contrast it with Solomon Partners' published position that its advice is "free of conflicts of interest, as we do not lend or underwrite." That lands against two documented patterns: UBS was Celsius Holdings' exclusive adviser on Alani Nu and simultaneously provided the committed $900M term loan B and $100M revolver, and on JDE Peet's, Morgan Stanley advised Keurig Dr Pepper while its affiliates provided underwritten financing. Both disclosed, legal and routine. Ask any bank to state in the engagement letter what else it is being paid for on your deal.

One more asymmetry I have not seen written down. Call it the BrokerCheck Gap, a Peony-original observation. Several of the best consumer specialists advise through a separately named affiliate broker-dealer:

Normal and legitimate — but a founder searching BrokerCheck for "Whipstitch Capital" finds nothing and walks away from one of the best-evidenced boutiques in the category. Search the affiliate name, not the brand name, and never describe Whipstitch itself as the FINRA member. The same discipline applies to your own diligence trail: the affiliate name is what belongs on the engagement letter, and the room's audit log is what proves later who read which page under it.

Some good advisers operate under the federal M&A-broker registration exemption instead. The size test is disjunctive: EBITDA under $25 million OR gross revenues under $250 million — either limb, not both (15 U.S.C. § 78o(b)(13)), and those figures do not inflation-adjust until December 29, 2027. Our persona clears both, so an exempt broker is lawful — see M&A advisor vs broker vs investment bank and the M&A solution page.

Who are the 16 consumer products M&A advisors on this bench, and how are they ranked?

By the strength and recency of their consumer adviser-of-record evidence, not by size. A firm publishing dated 2025-2026 consumer tombstones that a counterparty's SEC filing corroborates outranks a larger firm whose consumer credits are undated marketing. Where a firm's ownership is not stated on the pages I read, the table says so rather than repeating what everyone assumes.

Bottom line: for the best-evidenced consumer franchise in the middle market, Piper Sandler. For a better-for-you food or beverage brand under $500M, Whipstitch Capital. If you might go public instead of selling, William Blair. Everything else is category fit, and the profiles say exactly where each firm's evidence stops.

1. Piper Sandler — the best-evidenced consumer franchise in the middle market

Piper Sandler, headquartered in Minneapolis, is the only mid-market platform on this bench whose consumer sell-side role is corroborated by a counterparty's SEC filing. Flowers Foods' own 8-K names Piper Sandler and Centerview Partners as the financial advisers to Simple Mills on its $795M sale in January 2025 — the cleanest possible proof, because the buyer had no incentive to flatter the seller's bank. Three more dated 2025 credits sit on its own consumer page: Potbelly Corporation to RaceTrac (October 2025), Philz Coffee to Freeman Spogli (August 2025), and EoS Fitness to TSG Consumer (July 2025).

The practice is organized into eight verticals — Agriculture & Biorenewables; Beauty & Personal Care; Diversified Consumer Products; Food & Beverage; Health & Wellness Services; Restaurants; Retail & Disruptive Commerce; Vehicle Aftermarket Products & Services — and the firm reports more than 240 consumer transactions over the last five years and 70-plus investment banking professionals in the group. For European buyers, it acquired London-based Stamford Partners LLP in June 2022, forming its European food and beverage team, which matters more than it sounds: several of the growth-brand takeouts on the 2026 tape were cross-border (Ferrero, Danone, Henkel, ETi Gıda, Calbee, Ritter Sport).

Size band: only one of those four credits carries a published value — Simple Mills at $795M — which sits at the top of the range our persona could reach. Ask Piper for the values on the other three. For the Minneapolis bench in general, see our Minneapolis M&A advisors guide.

The honest caveat: Piper Sandler calls itself "the #1 Consumer M&A franchise in the middle market" and "the advisor of choice for best-in-class consumer companies." Those are the firm's own claims, published without a league-table citation on the page. I have quoted them because they are quotable, but treat them as marketing, not as an independent ranking. The Simple Mills filing is the fact; the "#1" is the pitch.

2. Whipstitch Capital — the best-evidenced consumer boutique in the United States

Whipstitch Capital, at 22 Boston Wharf Road in Boston, publishes five dated 2025-2026 sell-side credits, and one is confirmed in a buyer's SEC filing. That combination exists nowhere else in the boutique tier, and it is why Whipstitch ranks second on a bench that includes Goldman Sachs.

The confirmed one: Whipstitch advised Copra, Inc. on its sale to The Vita Coco Company, announced and closed the same day on July 22, 2026 — $175M upfront, plus an earnout payable in 2029 on 2028 performance with a $45M floor and a $100M cap. Vita Coco's 8-K states it verbatim: Evercore advised Vita Coco, Whipstitch advised Copra. A Boston sector boutique took the sell side against a large-cap independent and got a floored earnout on a business whose net sales were expected to exceed $100M in fiscal 2026. That is the most useful data point here for a founder deciding whether a boutique can hold its own.

The other four, all self-published with dates, all as exclusive financial adviser: Chocolove to Ritter Sport, November 26, 2025; a majority stake in Hodo to Calbee, September 16, 2025; Willamette Valley Pie Company to Dessert Holdings, September 16, 2025; and Presence Marketing to PLTFRM, March 10, 2025. Chocolove and Hodo are cross-border sales to German and Japanese strategics — a working franchise, not a logo wall. See our Boston M&A advisors guide.

Two precision points usually mangled elsewhere. The self-description is "the largest founder-led, independent M&A and private placement advisory firm in the US solely focused on better-for-you and emerging consumer brands" — every qualifier is load-bearing. And the "over 170 transactions since 2004" figure is the Whipstitch Team's count, not the firm's own since founding.

The honest caveat: Whipstitch Capital is not itself a FINRA member. Securities are sold through BFY Securities, LLC, the FINRA and SIPC member — the BrokerCheck Gap in action, and the most common way a founder mis-diligences this firm.

3. William Blair — the bank that can take your brand public instead of selling it

William Blair, Chicago, publishes seven dated 2025-2026 consumer credits — the deepest dated set of any mid-market platform here — and two of them are the differentiator: the Suja Life IPO in May 2026, raising $186.7M, and the Once Upon a Farm IPO in February 2026, raising $197.9M. No other firm on this bench took a better-for-you consumer brand public in 2026. If your board is genuinely weighing a sale against a public listing, that is not a tiebreaker, it is the whole conversation.

Its M&A credits are dated too: Ortholite (Trilantic) to Coats Group plc, October 2025, $770M; Better Being Co. (HGGC) to Snapdragon Capital Partners, December 2025; Thibaut (Norwest Equity) to Quad-C Management, May 2026; VIP Petcare (PetIQ/Bansk) to Tractor Supply, May 2026; and DecoPac (Kohlberg) to Sentinel Capital Partners, July 2026. The self-described coverage is broad in the ways that matter to this reader: "consumer products, consumer services, consumer technology and e-commerce, food, beverage and agriculture, consumer driven health and wellness, beauty and personal care, pet, automotive aftermarket, multisite retail, and restaurants." For the wider Chicago bench see our Chicago M&A advisors guide.

The honest caveat, and it is a precision point rather than a knock: DecoPac to Sentinel Capital appears on both William Blair's and Harris Williams' consumer pages, so neither firm can be given sole credit for it. Note also that most of the dated M&A credits are sponsor-to-sponsor or sponsor-exit transactions rather than founder sell-sides, and that the firm's ownership is not stated on the pages I read. If your process is a founder's first and only sale, ask specifically for founder references, not sponsor ones. And taking Suja Life and Once Upon a Farm public is a capital-markets capability staffed by a different team from the sell-side one. Ask which team would run your process.

4. Centerview Partners — the independent with the widest consumer range

Centerview Partners LLC is a New York independent advisory firm, and in this period it did something unusual: it appeared on both the largest consumer deal on the tape and on a $795M better-for-you food deal. On the sell side it advised Simple Mills on its $795M sale to Flowers Foods, co-advising with Piper Sandler, and it advised Kenvue on the pending Kimberly-Clark transaction, co-advising with Goldman Sachs. On the buy side it was PepsiCo's lead financial adviser on poppi, alongside J.P. Morgan. Both roles are confirmed in counterparty SEC filings, not in marketing material.

That range is the reason it ranks fourth here rather than lower. Most large-cap independents show up in consumer only at mega-cap scale; Centerview shows up at $795M too, and it shows up as the seller's adviser on a founder-and-sponsor-owned better-for-you brand — which is the exact profile of the reader this guide is written for, just three or four years further along. As an independent advisory firm it has no balance sheet in your deal — though unlike Solomon Partners it does not publish that position, so ask for it in writing. Consumer sell-sides at this scale are routinely run by a pair of banks rather than one: on Simple Mills it sat alongside Piper Sandler, and on Kenvue alongside Goldman Sachs. Centerview is consistently the independent half of that pair.

The honest caveat: the evidence base for Centerview in consumer is three deals, all large. There is no published record here of a sub-$500M consumer mandate, no named consumer sub-sector taxonomy on the scale that Piper Sandler or Baird publish, and no consumer research franchise. If your enterprise value is $60M-$150M, this is not your firm — and a bank that takes the meeting anyway is a bank you should ask hard questions about staffing.

5. Goldman Sachs — the most consistent sell-side name in the branded-consumer mega-exit

Goldman Sachs & Co. LLC advised the seller on four of the largest branded-consumer exits of the review period: poppi to PepsiCo ($1.95B, closed May 2025); WK Kellogg Co to Ferrero ($3.1B, closed September 2025); Kellanova to Mars (~$35.9B, closed December 2025); and Kenvue to Kimberly-Clark (pending). No other firm on this bench appears on that many large sell sides, and every one of those roles is verifiable in a counterparty's 8-K.

The proxies also make Goldman the one firm here whose consumer fees are public. On Kellanova its engagement letter provided a transaction fee of approximately $93.2M on completion, $5M of which was payable on announcement. On WK Kellogg it provided $2M payable on execution of the merger agreement plus a transaction fee of at least $18M and no more than $20M, at the board's sole discretion, contingent on consummation. Those two data points are the empirical backbone of the fee section below, and they are worth more to a founder than any adviser's rate card. Note the division of labour: on Kellanova, Goldman advised the company while Lazard separately advised the Board of Directors, and on Kenvue it co-advises with Centerview. At this scale a single bank rarely carries a consumer sell-side alone.

The honest caveat: I found no evidence of Goldman in the sub-$500M founder-brand lane, and I would not expect to. This is a scaled-exit adviser, built for public-company counterparties above roughly $1B of enterprise value. If you are a $60M-revenue brand, the useful thing about Goldman is not that you will hire it — it is that the strategic buying you may well have hired it, and knowing how that side is staffed and paid is part of negotiating against it. Buyers looking at this from that side should read how to acquire a company.

6. J.P. Morgan — the only bank working both sides of consumer at volume

J.P. Morgan Securities LLC is the rare firm that shows up as both the seller's and the buyer's bank in the same category and the same period. On the sell side it advised Alani Nu on its sale to Celsius Holdings, rhode on its sale to e.l.f. Beauty (co-advising with Moelis), and General Mills on the exclusive sale of its North America yogurt business to Lactalis and Sodiaal for $2.1B. On the buy side it advised PepsiCo on poppi and Kimberly-Clark on the pending Kenvue acquisition, co-advising with PJT Partners.

For a founder, the interesting item on that list is the exclusive General Mills mandate. Carve-outs of a corporate division are a different craft from selling a founder-owned brand — separate financials, transition services agreements, a supply relationship that must survive the sale — and that is precisely the kind of asset flowing out of the mega-cap portfolio-surgery lane described above. A bank that runs those knows what the divesting strategic will and will not concede, and those carve-outs are exactly what the mega-cap portfolio-surgery lane keeps producing. The rest of its record is co-advisory: it shared the rhode sell side with Moelis, the Kimberly-Clark buy side with PJT Partners, and PepsiCo's poppi mandate with Centerview. The mandates it held alone in this dataset are the Alani Nu sell side and the General Mills yogurt carve-out.

The honest caveat: working both sides at volume is a strength and a conflict surface at once. A bank whose franchise depends on repeat mandates from the same handful of strategic acquirers is a bank whose incentives on your one-time sale are worth examining directly. Ask which strategics it has advised in your category in the last twenty-four months, and get the answer in writing before you sign. Size band: every credit here is above $1B, with the yogurt carve-out the closest to a mid-market process.

7. Lazard — the only adviser here that publishes a checkable deal list

Lazard advised Siete Foods on its $1.2B sale to PepsiCo, and the proof is unusually clean: Lazard's own SEC-filed quarterly release lists the transaction with the client's name set in italics, per its stated convention. That makes it the only firm on this bench whose consumer credits are self-attested inside a document filed with the SEC rather than on a marketing page — a genuinely different evidentiary standard, and the reason it ranks seventh rather than tenth.

Its buy-side and board-side record in consumer is broad: lead adviser to Ferrero on the $3.1B WK Kellogg acquisition, with BofA Securities as co-adviser; adviser to Keurig Dr Pepper on JDE Peet's, alongside Morgan Stanley; and adviser to Kellanova's Board of Directors on the Mars transaction, separate from Goldman Sachs, who advised the company. That board-adviser role is worth understanding as a category: on a controlled or founder-influenced sale, a separate financial adviser to the board is how a company documents that directors took independent advice, and the Kellanova proxy shows what it cost — a $10M fee payable on consummation, of which $2M became payable on delivery of the fairness opinion.

The honest caveat: Lazard's consumer record here is four deals, all at scale, and three of them are buy-side or board-side rather than founder sell-side. A checkable deal list is a real advantage over an unfalsifiable one, but it is a list of large transactions. One caveat on sourcing: the $23B JDE Peet's figure in Lazard's quarterly release is a single firm's characterisation of a deal it worked on — KDP's own release states €15.7B of equity consideration. The $3.1B WK Kellogg and $35.9B Kellanova figures come from the targets' own 8-Ks, not from Lazard. Below $500M, the category boutiques — Whipstitch, Arlington and Cascadia — have more relevant, more recent, more granular evidence.

8. Harris Williams — the deepest sponsor relationships, and not one dated credit

Harris Williams, Richmond, runs a named Consumer Industry Group, and it is PNC-owned, as it has been since 2005. Its published consumer credits are genuinely relevant to this reader — Woof to The Farmers Dog; California Olive Ranch to Cobram Estate; Vesta Foodservice to Olympus Partners; Brothers International to SK Capital Partners; Beaba Suavinex Group to Portobello Capital; DecoPac to Sentinel Capital — spanning pet, food, foodservice and juvenile. On category fit alone it belongs in the top half of this bench.

What it buys you is buyer access. Harris Williams' published flow is heavily sponsor-to-sponsor, which is what you want if the thesis for your brand is a broad, competitive auction rather than a targeted approach to three strategics. Given that consumer is only about 65% strategic and that sponsors paid the higher median multiple in 2025, an adviser whose franchise is built on sponsor coverage is arguably better positioned in this category than in most. Richmond is also a genuine mid-market hub in its own right — see our Richmond M&A advisors guide.

The honest caveat, and it is the reason Harris Williams ranks eighth rather than second: its transactions page publishes no dates and no cumulative deal count. Every credit listed above is undated. Under the evidence standard this guide applies, an undated tombstone tells you a firm did a deal at some point; it does not tell you the team that did it is still there, still active, or still covering your subsegment. Ask for the closing dates and the deal team, in writing, in the first meeting. Its wider list reaches well beyond food — Healf to Semcap, The Travel Agent Next Door to Travel Counsellors, Bain Capital and Sixth Street into Power Home Remodeling — so the group defines consumer broadly. Pin down subsector-specific experience early.

9. Solomon Partners — the sharpest published position on adviser conflicts

Solomon Partners, New York, is an independently-run affiliate of Natixis, and its own site describes a strategic relationship with Natixis. It publishes seven dated 2025-2026 credits, one corroborated by the counterparty: Second Nature Brands / Tillamook Country Smoker, where Insignia Capital Group's completion release of August 10, 2026 names Solomon as financial adviser to Second Nature Brands, the buyer, opposite Houlihan Lokey for the seller. The rest: Dossier to American Pacific Group, March 2026; Guess? to Authentic Brands Group, January 2026; the Stance asset sale to Marquee Brands, November 2025; and the VERA WANG intellectual-property sale to WHP Global, January 2025. It also advised Neiman Marcus Group on its sale to Saks Global in December 2024, Steve Madden and Kurt Geiger in May 2025, and ROUVY's sale to Zwift in April 2026.

It ranks ninth on one published sentence: its advice is "free of conflicts of interest, as we do not lend or underwrite." That is the sharpest articulation of the independent-versus-balance-sheet argument on this bench, and it lands directly against the UBS/Alani Nu and Morgan Stanley/JDE Peet's patterns above. Whatever you conclude, it gives you a specific question for every bank you interview. New York depth generally is in our NYC M&A advisors guide.

The honest caveat: the flow is retail, apparel and brand-intellectual-property heavy rather than food-and-beauty consumer packaged goods — and on Second Nature Brands it advised the buyer, not the seller, which is a different mandate from the one you would be hiring it for. Dossier, a fragrance brand, is the packaged-goods-adjacent exception. Brand IP, licensing and apparel platforms are where this bench is genuinely deep; if your exit is a trademark-and-licence sale rather than an operating-business sale, that is exactly the expertise you want. Size band: Guess? and Neiman Marcus at the top, Dossier and Stance at the boutique end.

10. Intrepid Investment Bankers — one of only two named beauty and personal-care benches

Intrepid Investment Bankers was founded in 2010 by Ed Bagdasarian and is headquartered in the Brentwood district of Los Angeles, with offices in San Francisco, Chicago, Nashville, Charlotte and New York. It has been MUFG-owned since January 2019 and is a member of FINRA and SIPC. It runs named groups in Beauty, Personal Care & Wellness and in Food, Beverage & Agriculture, plus Lifestyle Brands and Restaurant & Franchise Concepts — and it is one of only two firms on this bench with a group named specifically for beauty and personal care, the other being Robert W. Baird — Lincoln International folds beauty into a broader Fashion, Beauty & Apparel practice.

That matters because of what the multiples say. Beauty averaged 14.9x EV/EBITDA in YTD 2025 against a 9.8x consumer average (Capstone Partners, December 2025) — more than five turns of premium — and public strategic buyers were coming back into the category after collapsing to 9% of volume in 2024. If you run an indie beauty or personal-care brand, you are selling into the highest-multiple pocket in consumer, and the number of mid-market platforms with a group actually named for it is two. Los Angeles is also where a disproportionate share of indie beauty is built; see our Los Angeles M&A advisors guide, and how to sell a beauty brand for the category-specific process.

The honest caveat, stated plainly: Intrepid's published credits carry no dates, and the ones on its page are not beauty. Snak King to Falfurrias Management Partners, Cloudco Entertainment to IVEST, Drum Workshop to Roland, Star Waggons to Hudson Pacific Properties, a GLD majority recapitalization, Service Champions to Wrench Group. Snak King is a real food credit; the rest are lifestyle, entertainment and services. So the beauty group is real as a group, and unevidenced as a deal record on the pages I could read. Ask for dated beauty tombstones in the first meeting. Also note: Intrepid has been MUFG-owned since January 2019, so it is not an independent, whatever a directory tells you.

11. CG Sawaya Partners — the consumer-health and supplements specialist inside Canaccord

CG Sawaya Partners is the consumer M&A business Canaccord Genuity acquired in December 2021, and it now operates inside that firm — sawayapartners.com redirects to canaccordgenuity.com. It describes itself as "a premium independent M&A advisory business with deep domain expertise in the consumer industry," covering Food & Beverage; Health & Wellness; Home & Auto; Outdoors.

Its headline credit is a real carve-out, and it is corroborated on the buy side by an SEC filing. CG Sawaya advised Foundation Consumer Healthcare on the divestiture of Breathe Right, Dimetapp and Anbesol to Prestige Consumer Healthcare — US$1.045B, announced March 20, 2026, at roughly 11.0x EBITDA on about $200M of revenue and about $95M of EBITDA trailing to December 31, 2025. Prestige's own 8-K names Citi as its exclusive buy-side adviser, which is how you corroborate a boutique's tombstone without taking its word for it. Two further mandates are on its page and both are pending as of September 2026: Jamieson Wellness to Kirin Holdings at C$2.5B, and Thorne to Procter & Gamble at US$3.8B. Write them as pending, because that is what they are.

For a consumer-health, supplements or over-the-counter brand — a category where better-for-you and functional positioning drove 69.2% of strategic food acquisitions in YTD 2026 — this is the most category-specific bench on the mid-market tier.

The honest caveat: the "premium independent" self-description sits awkwardly with being a bank subsidiary. Never describe this firm as independent Sawaya Partners — it has been inside Canaccord Genuity since December 2021, and the ownership is the disclosure. And because two of its three flagship credits are pending, re-check their status yourself before you use them as evidence of anything. A pending deal proves a mandate was won, not that it closed on the terms announced. Size band: $1B to C$2.5B on the three flagship credits, so ask what it runs below $200M.

12. Lincoln International — six consumer subsectors and a research cadence

Lincoln International, Chicago, covers consumer across six subsectors — Consumer Products; Consumer Services, which the firm calls its fastest-growing segment; Fashion, Beauty & Apparel; Food & Beverage; Retail & Restaurants; and Travel & Leisure — with named consumer leadership in three cities: Christopher Petrossian in Los Angeles, Christopher Stradling in Chicago and Monika Nickl in Munich. Named leadership is a small thing that tells you something real: it means there is a person accountable for the category rather than a generalist who covers it when a deal appears.

The research cadence is the second signal. Lincoln publishes quarterly reviews for Fashion & Apparel, Food & Beverage, Online Retail, Consumer Health and Active/Outdoor Brands, plus sports-technology reports. A firm that has to produce a food and beverage quarterly is a firm that has to keep talking to buyers in the category between mandates. Its food credits are genuinely mid-market and genuinely relevant: Highland Baking Co. to Europastry; FreshPure Waters (Rise Run Capital) to TowerBrook Capital Partners; Dalziel to Peak Rock Capital; Wells Vehicle Electronics to Olympus Partners; Infratech to Platinum Equity; plus a Kids2 credit-facility refinancing and a DT Swiss founder-succession-and-refinancing mandate. That last one matters for a founder reader: succession and recapitalization are alternatives to an outright sale, and not every mid-market bank runs them.

The Munich seat matters: several 2026 growth-brand buyers were European strategics, and a Chicago-plus-Munich team reaches them better than a domestic-only bench. See our Chicago M&A advisors guide.

The honest caveat: none of those credits is dated on the page. Lincoln has real mid-market food credits and a real research franchise; what it does not publish is when any of it happened. Under this guide's standard that costs it several places. Ask for closing dates and for the two most recent food and beverage transactions the named leads personally ran.

13. Houlihan Lokey — one verified 2026 consumer sell-side, and a site you cannot read

Houlihan Lokey runs a named Consumer, Food & Retail Group covering consumer products, food and beverage, and consumer channels and leisure, plus three recurring conferences: the Global Consumer, Food & Retail Conference in New York; the European Consumer, Food & Retail Conference; and the Global Consumer Conference in London. A firm that convenes the category three times a year has the buyer relationships that come from convening it, and its newsroom shows continued senior hiring into the group.

It has exactly one 2026 consumer sell-side credit that clears this guide's standard, and it is a good one. Houlihan Lokey acted as exclusive financial adviser to Tillamook Country Smoker and its sponsor Insignia Capital Group on the sale to Second Nature Brands, announced June 8, 2026 and completed by August 10, 2026 — stated verbatim in Insignia's own completion release, with Kirkland & Ellis as sellers' counsel. Terms were not disclosed. That is a meat-snacks brand sold out of a private-equity portfolio to a sponsor-backed platform buyer, and the same release names Solomon Partners on the buy side.

The only other places Houlihan Lokey surfaces in a consumer-adjacent SEC document in this window are as financial adviser to private investment firms including Sweat Equities in a 2025 Village Farms International transaction, and as a named party in Beyond Meat's September 2025 liability-management exhibit. Neither is a branded-consumer sell-side M&A credit, and I list them so you see the whole of what I found.

The honest caveat is still real. Houlihan Lokey's website is bot-protected end to end — the group and conferences come from its public sitemap, and its deal record from counterparties. Its FY2026 Form 10-K for the year ended March 31, 2026 does not name its industry groups; the word "Consumer" does not appear in it. So: one verified, dated, side-attributed consumer sell-side against Piper Sandler's and Whipstitch's several, and no claim from me about any league-table rank. That is why it sits at thirteen — not because the franchise is thin, but because the public evidence for it is.

14. Robert W. Baird — the deepest subsector map, led by capital markets

Robert W. Baird, Milwaukee, is employee-owned and organizes consumer coverage into thirteen subsectors: Active Lifestyles/Fitness & Mobility; Beauty & Wellness; Healthy Living, Food & Beverage; Household Products; Juvenile & Toy; Marine/Powersports/RV; Multi-Unit Restaurants & Franchising; Outdoor Recreation & Sporting Goods; Performance & Lifestyle Apparel and Footwear; Pet Care; Sportsman; Travel/Leisure/Hospitality; and Vehicle Aftermarket. That is the most granular consumer taxonomy on this bench, and four of those subsectors — Beauty & Wellness, Healthy Living Food & Beverage, Household Products, Pet Care — are exactly this reader's categories.

The research franchise is live and dated, which is rarer than it should be: "Fueling Growth: Consumer and M&A Themes in Nutritional Supplements" (November 2025), "Baird's Leading Food Processing Momentum" (July 2026), an inaugural Food Processing Equipment Symposium recap (March 2026), an Organized Sports Industry Report (2025), plus a Beauty & Wellness Quarterly Update series and a Consumer Products Monthly Update series. Employee ownership is also a genuine structural point in the conflicts discussion above: there is no parent bank whose lending relationships sit behind the advice.

The honest caveat, and it changes how you should use this firm: every consumer transaction showcased on Baird's consumer page is an equity capital markets role, not an M&A adviser-of-record role. The Jersey Mike's Subs $1.0B IPO, the Reformation $210.9M IPO, the Savers Value Village $235.8M follow-on, the Bob's Discount Furniture $330.7M IPO, the Black Rock Coffee Bar $338.2M IPO, the Birkenstock $1.1B follow-on. Those are impressive and they are not sell-side M&A. An equity capital markets desk sells a story to hundreds of investors at a price the market sets; a sell-side M&A team negotiates one price with one counterparty. Different skills. Frame Baird as a capital-markets-led consumer bank, and if you interview it, ask for consumer sell-side M&A tombstones with dates — they may well exist, they were simply not on the page I read.

15. Arlington Capital Advisors — the deepest dated beverage and distribution bench found

Arlington Capital Advisors, at 2000 Morris Avenue in Birmingham, Alabama, is a boutique focused exclusively on consumer businesses, describing itself as "Trusted Thought Partners to Leading Consumer Brands" and concentrating on food and beverage — breweries, restaurants, beverage brands and the distribution around them. First, the disambiguation, because it matters: this is not Arlington Capital Partners, the Washington DC private equity firm. Different firm, different business, similar name.

It publishes six dated 2025-2026 credits — more than any mid-market platform on this bench publishes with dates: Stone Distributing Company to Hand Family Companies, May 2025; Carenbauer Distributing to Waldorf Distributing, April 2025; Tenzing Natural Energy's investment from Heineken UK, April 2025; Northern Monk's partnership with Damm, March 2025; Bill's Distributing to S&S Distributing, 2026; and Finnish Long Drink to Mark Anthony Group, 2026.

Read that list carefully, because it is a specific and unusual specialty. Three are beverage distribution transactions — the wholesale tier that most consumer bankers never touch and most founders never think about until a distributor consolidation changes their route to market. Two are inbound investments from European brewers into UK brands. One is a spirits-adjacent sale to a major. Against a beverage market that ran 12.2x on average across 2024-2025 and was 84.3% strategic with public strategic participation at its lowest share since 2016 (Capstone Partners, March 2026), a firm whose whole book is beverage and its distribution is doing something structurally different from a generalist.

The honest caveat: the principals are licensed with Arlington Capital Services, LLC, a FINRA and SIPC member affiliate — the BrokerCheck Gap again. And the book is narrow by design. If you make a snack, a supplement or a skincare line, this firm's dated evidence does not cover you. Two of the six credits carry only a year rather than a month.

16. Cascadia Capital — real dated credits, and not the food-and-beverage bench it is usually described as

Cascadia Capital, Seattle, a FINRA and SIPC member, runs a Consumer, Retail & E-Commerce group covering e-commerce and retail; consumer products spanning apparel, footwear, home furnishings, luxury and pet; and consumer services including personal care, beauty, pet services and fitness. It describes its edge as a "deep understanding of the underlying consumer trends driving disruptive change" and "constant dialogue with active strategic and financial buyers and investors in the consumer sector."

Its dated credits are real and recent: Corkcicle to a private investor group, September 16, 2025; Badgley Mischka to ACI Licensing and Established Incorporated, April 16, 2025; Mann Lake Bee & Ag Supply to a private investor group, April 3, 2025; 4moms (Thorley Industries) to UPPAbaby, July 24, 2024; and Knot Standard to Billy Reid, April 25, 2024. Five dated credits in seventeen months, from a single regional bench, in a market where most firms publish no dates at all. Seattle's broader bench is in our Seattle M&A advisors guide, and if your business is more channel than brand, our e-commerce solution page and how to sell an e-commerce business are the closer fit.

The honest caveat, and it is a reframe rather than a knock. Cascadia is routinely described as a food, beverage and agriculture practice. The dated credits on its consumer page are drinkware, designer apparel, juvenile products and bee-and-agriculture supply. Not one is a branded food or beverage sale. The firm does maintain a food, beverage and agriculture practice, and dated food credits may well sit on that separate page — I did not retrieve one. So: a real consumer boutique with a real dated record in consumer products, juvenile and apparel. If you are selling a functional beverage, ask it directly for dated food and beverage tombstones before you assume the specialty transfers. Size band: middle market, roughly $50M-$500M of enterprise value, per our Portland guide.

Which large-cap banks actually advised on the 2025-26 consumer exits?

Four firms carried the sell side of nearly every mega-exit in the period — Centerview Partners (profile 4 above), Goldman Sachs (5), J.P. Morgan (6) and Lazard (7) — and a second group of eight, tabled below, appears in supporting or buy-side roles. These are the right call above roughly $1B of enterprise value and the wrong call below it, for the fee reasons set out above.

The large-cap credits ledger: eight more banks and what they actually did

These firms each appear in the ledger above but are not ranked, because a single credit — however large — is not a consumer franchise. Their roles matter anyway: these are the banks likely to sit across the table from you.

Bottom line: four of the eight — UBS on Alani Nu, Morgan Stanley on JDE Peet's, RBC on Simple Mills and BofA on Utz — advised a buyer and helped finance the same deal, disclosed in the parties' own filings. Citi did the same for Mars on Kellanova. That is not an exception in this tier; it is the norm, and exactly what an independent like Solomon Partners argues against. Ask about it explicitly.

Which mid-market platforms have a real consumer group with dated deals?

Nine do — Piper Sandler (profile 1 above), William Blair (3), Harris Williams (8), Solomon Partners (9), Intrepid Investment Bankers (10), CG Sawaya Partners (11), Lincoln International (12), Houlihan Lokey (13) and Robert W. Baird (14) — and the gap between the best-evidenced and the least-evidenced of them is wider than any brand-recognition ranking would suggest. This is the tier that covers roughly $150M to $1B of enterprise value, and it is where most branded consumer sellers should start.

Not ranked, but read anyway: Capstone Partners, the research authority

Capstone Partners is the source of most of the market data in this guide and the best-documented consumer research franchise in the middle market: the Annual Consumer M&A Report dated April 27, 2026; a Food M&A Update dated April 30, 2026; a Beverage Sector M&A Update dated March 17, 2026; a Beauty M&A Update dated December 4, 2025; an Apparel, Footwear & Accessories report dated July 17, 2026; a Vitamins & Supplements update dated June 17, 2026; and a Sports Technology update dated August 27, 2026. Real edition dates on every one, which is why I can cite them precisely. The reports also name the strategic and sponsor buyers active in each sub-sector by quarter — the cheapest way to sanity-check an adviser's proposed buyer list.

I have not ranked it, on the same standard applied to everyone else. The consumer transactions Capstone displays are auto aftermarket, apparel retail and manufacturing — Wilbar Group to StoneTree (2026), an online apparel retailer to a family office (May 2026), Rent to Retirement to Calidant Capital (April 2026), Max Auto Supply to Midas International (December 2025), Left Lane Auto to Bertram Capital (December 2025), Freedman Seating to Lippert Components (April 2025). None is food, beverage or beauty consumer packaged goods. Cite Capstone as the category's research authority. Do not hire it as a food-and-beverage sell-side bench on the strength of its research. And note the ownership: Capstone Capital Markets LLC is a subsidiary of Huntington Bancshares — not independent.

Which category boutiques should a $50M-$500M brand call first?

Three — Whipstitch Capital (profile 2 above), Arlington Capital Advisors (15) and Cascadia Capital (16) — and for the persona this guide is written for they are the most relevant firms in it. A category boutique's edge is not size. It is that the partner running your deal has spoken to the specific category manager at the specific strategic who is hunting your specific subsegment this quarter — and at $60M of revenue, that is worth more than a bigger logo.

Who did we leave off — and why?

Sixteen firms that appear on other consumer lists are not ranked here. The standard is a dated 2024-2026 consumer adviser-of-record credit in a primary source — a named consumer client, a named counterparty and a date. Every firm below is real; what is missing is public, dated evidence that they advised a consumer-products seller in the last two years.

A consumer practice, no dated credit found. Silverwood Partners of Sherborn, Massachusetts, a FINRA and SIPC member, shows logos only, no acquirers, no dates — and a trap: its dated February 19, 2026 homepage items on Chowbus, World Labs and Altesa BioSciences are its weekly market-update newsletters covering other parties' deals, not Silverwood transactions. Tully & Holland, Boston, established 1992, a FINRA and SIPC member across fifteen consumer segments, is active and published a Q2 2026 industry report, but its tombstones are undated and several are code names such as Project King and Project Clean Beauty. Brookwood Associates of Atlanta is a real regional bank whose consumer logos are restaurant and franchise concepts — Wild Eggs Holdings, Barberitos, Bel Air Cantina, Franworth. SDR Ventures, Greenwood Village, Colorado, has consumer and pet practices but thin flow: Imagine Baking in 2024, Kenny's Great Pies in 2022. Hyde Park Capital of Tampa "acted as the exclusive financial advisor to No Cow and Good Karma Foods" on their sale to Trek One Capital but publishes no date; it was named to the Axial Advisor 100 for 2026.

Generalists with food and beverage as one vertical among many. CLA Meridian Capital, part of CliftonLarsonAllen — never independent Meridian Capital — names Dorsing Farms, Ellenos Greek Yogurt, Boyer and See Kai Run without acquirers or dates. The Peakstone Group of Chicago serves $10M-to-$500M-revenue companies with food and beverage one of fifteen-plus verticals, its deal list behind a registration gate. Mesirow, employee-owned, founded 1937, names only an architectural-products transaction on its investment banking page. TM Capital's consumer research is a Consumer & Retail Monthly dated April 2018; Brown Gibbons Lang's Consumer Products & Retail Services Insider shows August 27, 2013 as its only dated edition.

Not consumer M&A advisers at all. Benchmark International, whose "Ranked #1 Sell-side, Privately-Owned M&A Advisors in the World" claim names no awarding body — self-awarded. First Bev, formerly First Beverage Group, now describes a private equity firm focused exclusively on beverage; classify it as a buyer.

Finally, quality I cannot evidence. Jefferies, Stifel, Guggenheim and Raymond James are all firms I would expect to have consumer coverage. I could not confirm it: their consumer pages returned nothing to my fetcher, so I am not describing practices I could not read. No dated 2025-2026 consumer adviser-of-record credit surfaced for any of them in this pass. The one exception is Jefferies, whose fee on the 2024 Whole Earth Brands going-private is disclosed in that deal's proxy and cited in the fee section above — a 2024 credit, outside this bench's window. Note that financo.com now redirects to Raymond James' consumer and retail investment banking page; I could not confirm the date of that acquisition and do not state one.

For adjacent sectors, our healthcare M&A advisors and home services M&A advisors guides apply the same standard.

How do buyers use SPINS, Circana and NielsenIQ scanner data in diligence?

They use it to test whether your brand sells because it is good or because it is everywhere, and the first thing they do is convert your velocity claim into their unit. Call it the Velocity Unit Test, a Peony-original diagnostic.

Circana defines velocity as "sales per store, per TDP, or per million ACV," dividing sales by stores selling, total distribution points, or all-commodity volume "as needed," to "remove distribution bias in comparisons"; its worked example of grocery velocity is $150 per store per week. SPINS defines velocity as "Sales ÷ Distribution," where distribution can be store count, Max %ACV or total distribution points; its example over four weeks and 500 stores runs a value brand at $100 per store per week and 50 units per store per week against a premium brand at $120 per store per week and 30 units per store per week. Same concept, at least three incompatible units.

ACV is a weight, not a sales figure. Circana defines it as "the sum of total sales across stores in a market for all products, used as a weight to value store importance" — a market with $900,000,000 in quarterly store sales has that as its ACV. SPINS' Average %ACV measures average distribution between 0% and 100%, with Max %ACV as your "personal best"; a brand quoting 51.25% average ACV and one quoting Max %ACV are not describing the same thing.

A confidential information memorandum that says "velocity" without naming the unit, panel and period is not comparable to the buyer's benchmark file, and a buyer who cannot reconcile it will discount rather than ask. NielsenIQ's public dictionary page did not resolve in this pass, so I cite Circana and SPINS rather than a page I could not read.

Then they rebuild your margin, and trade spend is the vocabulary trap. Cadent Consulting Group's 2024 Marketing Spending Study, published September 23, 2024, found consumer packaged goods marketing spending up 1.7 percentage points since 2022 to 19.5% of sales — but that is total marketing spending: trade promotion plus consumer promotion plus advertising, not trade spend alone. Cadent's older editions breaking out the trade component are no longer live and there is no 2026 edition, so anyone quoting a precise trade-only percentage is not quoting a study. Distributor deductions with the major natural-channel wholesalers cluster around 2% to 15% of gross sales, up to roughly 20% including trade promotions, with 30-to-90-day dispute windows. That gross-to-net bridge belongs in your due diligence room fully reconciled before a buyer asks — which is what a sell-side quality of earnings engagement is for.

Does retailer concentration across Target, Whole Foods, Costco and Walmart hurt my valuation?

Less than the rules of thumb claim, and the filings prove it. First, a correction almost everyone gets wrong: the 10%-of-revenue customer disclosure threshold is a US GAAP segment-reporting rule, not an SEC business-description requirement. The SEC made Regulation S-K Item 101(c) principles-based effective November 9, 2020 (Release Nos. 33-10825; 34-89670); the retained topic is dependence on key products, services or customers, with no numeric threshold and no naming requirement. The prescriptive language survives only for smaller reporting companies under Item 101(h)(4)(vi). Now the evidence, all from the most recent fiscal-year 10-Ks:

Four public consumer brands, with top-two customer concentration running from 31% to 54% of net sales — e.l.f.'s top four are 52%, our arithmetic on its disclosed shares — and none priced as impaired. That beats any "above 40% costs you a turn" rule, which has no published source and is contradicted by these filings. What moves price is whether concentration is explained or discovered: documented program history, contract terms, private-label exposure and a credible diversification path are a discount you negotiate; the same facts surfacing in week six of diligence are a retrade.

Will a single co-manufacturer sink the deal?

It is a drafting question, not a market norm, and most people state it backwards. Under UCC § 2-210, "unless otherwise agreed all rights of either seller or buyer can be assigned except where the assignment would materially change the duty of the other party, or increase materially the burden or risk imposed on him by his contract, or impair materially his chance of obtaining return performance" — and a bare prohibition on assigning “the contract” is construed as barring only delegation of performance. Rights are assignable by default; the restriction, if any, is a clause your predecessor negotiated. Do not accept the claim that co-packer agreements "are generally not assignable" or "always require consent." What is sourced is that structure moves price: Auxo Capital Advisors' 2026 guide names co-manufacturing risk as a valuation drag, framing a brand at 8.0x-9.0x because "two national retailers represent a meaningful share of sales, promotional intensity is uneven, freight costs remain elevated, and co-manufacturing changeovers create yield loss." Fix assignability before you go to market, not during exclusivity.

One sourcing note: there is no published benchmark for the number of diligence requests in a consumer deal. Any list quoting a precise range is quoting itself. What is true is which documents come last: velocity by retailer, formulations and specifications, and co-manufacturing terms are last-tranche documents.

What do consumer products M&A advisors charge — and does the fee pay for itself?

A monthly retainer plus a contingent success fee, with the success fee scaling down as deal size rises. Expect a success fee in the low-to-mid single-digit percent of enterprise value on a lower-middle-market consumer sale, paired with a modest monthly retainer or work fee, often credited against the success fee at close. The original Lehman formula (5/4/3/2/1) is largely obsolete here; the modern form is "double Lehman" — roughly 10% of the first $1M of value, 8% of the second, 6% of the third, 4% of the fourth and 2% thereafter — or a negotiated flat percentage with a stated minimum. Get it in writing: retainer, scale, minimum, the tail period (the months after termination during which the adviser still earns a fee if you sell), and expenses. Treat any single figure as illustrative rather than a quote. For what the room costs against that fee see pricing; M&A advisor fees has the engagement-letter mechanics and home services M&A advisors works the same math for another sector.

Read the gradient. Two deals, one about 11.6 times the size of the other, and the smaller paid roughly 2.7 times the fee rate — Lehman-style regression demonstrated with SEC-filed numbers rather than a rate card. The mid-single-digit percentages quoted in the lower middle market are a different market, not a contradiction, so ask for the scale rather than the headline rate.

There is exactly one recurring published US fee study, and its numbers are gated. The Firmex M&A Fee Guide, 2024-2025 US edition, produced with Axial and Divestopedia from 212 M&A advisers, is the eighth annual and the latest. Its ungated findings are thin — only 30% of firms raised at least one type of fee last year, against 37% the prior year — and the retainer amounts and success-fee bands sit behind a form. A page quoting precise industry fee bands and gesturing at "industry surveys" is not quoting this one.

The arithmetic for our persona, illustrative and not a promise. On $8M of adjusted EBITDA, a direct uncontested negotiation with one strategic anchors near the 8.6x strategic median, about $68.8M; a process that genuinely puts sponsors in the room reaches toward the 10.4x sponsor median, about $83.2M — a $14.4M gross spread. Net a low-to-mid single-digit success fee on the higher number, call it $1.7M to $3.3M, plus a sell-side quality-of-earnings engagement, and you are ahead by well over $10M.

The honest counter-case: that assumes the process clears at the sponsor median, which is a median of the market rather than a forecast; that growth holds through a six-to-nine-month process; and that diligence finds nothing in the gross-to-net bridge. The fee pays for itself when the price lift is real, and whether it is real depends on whether a second credible bidder exists.

How long does it take to sell a consumer brand — and what slows it down?

Six to nine months from engagement to close — and everyone says six to nine months and nobody sources it. I looked for a bank-published or study-published consumer-specific timeline and found none. So here is our own practitioner stage map, labelled as exactly that: preparation weeks 1-6; buyer outreach weeks 4-8; indications of interest weeks 8-12; management meetings weeks 10-16; final bids and a signed letter of intent weeks 14-20; confirmatory diligence and closing 60-90 days under exclusivity. A planning skeleton, not a promise. Full sequencing is in our mergers and acquisitions process guide. Sign-to-close, by contrast, is observable:

Two lessons. Private-target deals in the $175M-$1.7B range close fast — six to ten weeks is normal, and Copra signed and closed the same day. If your process drags past that, the cause is usually an unresolved diligence item, not a regulator. The long gaps have specific causes: Kenvue's ten-plus months is a merger-control story, not a deal-quality story.

On regulators, 2026 was counterintuitive: the friction was foreign. The Hart-Scott-Rodino reporting floor is $133.9M, effective February 17, 2026, and the smallest filing fee is $35,000 — so a $60M-revenue brand selling at a $70M-$90M enterprise value may not trigger a filing at all. I found no FTC or DOJ challenge to a US food, beverage or beauty brand acquisition in 2025 or 2026. Mars/Kellanova cleared the EU unconditionally; Ferrero/WK Kellogg closed in under three months. The delays came from China's SAMR, which opened an in-depth review of Kimberly-Clark/Kenvue; Australia's ACCC, which cleared that deal on September 2, 2026 only after requiring the divestment of Carefree and Stayfree; and the UK's Competition and Markets Authority, which cleared Danone/Huel on August 21, 2026. The one consumer-side block was Henkel's $725M bid for Liquid Nails, which a court blocked on the FTC's challenge in August 2026 — construction adhesives, but a consumer-brands acquirer.

How do I keep the sale confidential from retailers, my co-packer and the strategic in my aisle — and where does Peony fit?

By deciding, document by document, who reads what and when — because the buyer most likely to pay you the most is also the party most dangerous to you if the deal dies. Four leaks: the category buyer at your retailer, where a rumour delays a line review and shows up as softening velocity in the exact scan data your buyers are underwriting; your co-manufacturer, who can reprice a renewal or turn a routine assignment into a consent negotiation on your timetable; the bidder who leaves with your formulation summary, usable whether or not they buy; and your own team, who find out from the room when access is not scoped.

The fix is staged access, run out of a room you control:

• A separate data room per buyer, with visitor groups walling competing strategics off inside one process.
• Staged disclosure: teasers and topline financials early; velocity by retailer, formulations, specifications and co-manufacturer terms in the last tranche, released only after a bid you believe.
• Per-viewer watermarks on every rendered page, so a leaked formulation summary traces to the exact party. Data Room plan and up.
• NDA gates before the room opens. Simple acknowledge-only NDA is on Business and up; Advanced NDA, where the viewer digitally signs and both sides receive a countersigned PDF with a full audit trail, is on Data Room and up.
• One-click revoke on Business and up, plus link expiry on every tier.
• Page-level analytics showing who lingered on the trade-spend build — the bidder who spent forty minutes on your gross-to-net bridge is about to ask for a retrade.
• Auto-indexing, structured Q&A, a custom domain, and the security layer underneath.

Peony is not an M&A advisor, takes no side in your sell-or-hold decision, and does not place deals — the firms above do that. We are the confidential room the process runs in: pick your advisor first, then stand up the room. See our M&A data room playbook and the M&A solution page. Peony is used by 6,800+ customers on exactly this layer.

On pricing: the Data Room plan is $52 per admin per month billed annually and is the tier a sell-side process wants — dynamic watermarking, Advanced NDA with countersigning, granular per-file permissions, auto-indexing, custom domain, unlimited rooms. Business is $30 per admin per month; Deal Team is $64 per admin per month billed annually with a four-admin minimum. Every tier includes unlimited free viewers, so inviting twenty strategics and eight sponsors costs nothing per head — which matters here, because a category where a third of buyers are sponsors is one where your buyer list should be long. See pricing.

The bottom line

Consumer M&A in 2026 is three markets wearing one label, and the costly mistake is reading the wrong one. The 9.2x industry median is a 10-year low and it is not your price if you are a growing branded business — food ran 12.7x on average in YTD 2026, snacks 16.9x, beauty 14.9x, and branded processed foods beat private label by four turns. Sponsors paid 10.4x against strategics' 8.6x in 2025, so a strategics-only process leaves the higher median bidder outside the room. And the bench is smaller than the lists suggest: thirteen firms carried the sell side of every deal I could verify.

Three questions decide your outcome. Which lane are you in? Can your adviser show you a dated consumer credit in a primary source, or only a logo wall? And who is allowed to read what, and when — because your best buyer shares your aisle, and formulations and velocity-by-retailer are last-tranche documents whether or not anyone tells you so. Pick the adviser whose dated evidence matches your category, then stand up the room. Buyers should start with how to acquire a company.

Related resources

• Best M&A advisors — the cross-sector hub this bench is a deep dive from, same evidence standard.
• How to sell a food and beverage brand and how to sell a beauty brand — the category process work this guide assumes you have done.
• How to sell an e-commerce business — if your revenue is more direct-to-consumer than retail shelf.
• Best building products M&A advisors and best home services M&A advisors — the 87.5%-strategic and sponsor-driven contrasts to consumer's 65%.
• Best healthcare M&A advisors — the same standard applied to a sector with harder regulatory gates.
• Consumer investors and independent sponsor consumer capital partners — the buy side of your process, mapped.
• M&A advisor vs broker vs investment bank and M&A advisor fees — the label framework and fee mechanics.
• M&A data room, mergers and acquisitions process guide and CPG fundraising data room — how the confidential process is run.
• How to acquire a company — for buyers on the other side of the table.
• Peony features: data rooms, watermarks, NDA gating, page analytics, auto-indexing, custom domain, security — plus pricing and the M&A, due diligence, private equity, e-commerce and fundraising pages.

Frequently asked questions

Is 2026 a good time to sell a better-for-you food or beverage brand?

Yes for a growing better-for-you brand, but not for the reason the headline suggests. The 2025 consumer median was 9.2x EV/EBITDA, a 10-year low against a 10.5x 2016-2025 median, with volume down 18.9% (Capstone Partners, April 2026). That median is not your price. Food deal volume rebounded 66.7% year over year in early 2026, branded food deals more than tripled to 77.5% of volume, and better-for-you targets were 69.2% of strategic and 85.7% of private-equity food acquisitions. At roughly $60M of net revenue, 25% growth and $8M of adjusted EBITDA, you are priced in the growth-brand lane, not against the industry median.

We got unsolicited inbound from a strategic in our aisle — should we run a formal process or just negotiate with them?

Take the meeting, but do not let it become the process. A single bidder gives you no price discovery, and the 2025 medians show the cost: strategics cleared at 8.6x while private equity cleared at 10.4x (Capstone Partners, April 2026). On your $8M of adjusted EBITDA that gap is roughly $14M of enterprise value, which dwarfs any adviser fee. The middle path is a targeted process of six to twelve buyers rather than a broad auction — enough tension to move price, few enough parties to control leaks in an aisle where your bidders talk to your retailers. Run the inbound party inside it on the same timetable. Peony's unlimited free viewers mean a twelve-buyer process costs nothing per head, unlike legacy rooms priced per deal, such as Datasite at around $68,000 for a deal-scale engagement.

I'm selling a $60M better-for-you brand — who are the best M&A advisers for a consumer products company?

The ones with a dated adviser-of-record credit in a primary source for your category, which is a shorter list than most directories suggest. Large-cap banks — Goldman Sachs, J.P. Morgan, Centerview Partners and Lazard — carried the sell side of nearly every consumer mega-exit of 2025 and 2026, all verifiable in counterparty SEC filings. Mid-market platforms cover roughly $150M to $1B: Piper Sandler, whose Simple Mills role is confirmed in Flowers Foods' own 8-K; William Blair, with seven dated credits including two consumer IPOs; plus Harris Williams, Solomon Partners, Intrepid, CG Sawaya Partners, Lincoln International, Houlihan Lokey and Robert W. Baird. Category boutiques cover $50M to $500M: Whipstitch Capital, Arlington Capital Advisors and Cascadia Capital.

Bulge-bracket bank, mid-market platform or category boutique for a $60M consumer brand?

A mid-market platform or a category boutique, almost certainly not a bulge-bracket bank, and the reason is fee economics. Goldman Sachs earned about 0.26% of enterprise value on the $35.9B Mars/Kellanova deal and up to 0.71% on the $3.1B Ferrero/WK Kellogg deal, our arithmetic on the two filings. Scale that curve to the $70M-$90M enterprise value your $8M of EBITDA implies and the absolute fee no longer funds a properly staffed process. A boutique instead gives you category-specific buyer intelligence — which category manager at which strategic is hunting your subsegment this quarter. Whipstitch Capital's Copra sale to Vita Coco, at $175M upfront against Evercore on the buy side, proves a boutique can hold that table.

Will my brand be priced on a revenue multiple or an EBITDA multiple?

On EBITDA, unless a strategic has a distribution thesis that makes your revenue worth more inside their system than your earnings are standing alone. The tape shows when the switch happens: Flowers Foods paid 3.3x revenue for Simple Mills against $240M of 2024 net sales growing 14%, and e.l.f. Beauty paid about 3.8x on closing consideration for rhode against roughly $212M of net sales. Both were high-growth brands with an acquirer who could drop them into an existing distribution machine. The gate is not growth alone, it is your trade-spend-adjusted gross margin, because a buyer paying on revenue is underwriting the margin they believe they can run.

What multiple do consumer products companies sell for in 2026 — is 9x fair, or am I being lowballed?

Nine times is the industry median, not your quote, and for a growing branded business it is probably low. The consumer median was 9.2x EV/EBITDA in 2025, a 10-year low against a 10.5x 2016-2025 median (Capstone Partners, April 2026). Segment matters far more: food averaged 12.7x in YTD 2026, snacks public comps 16.9x, branded processed foods 11.6x against private label 7.6x, and beauty 14.9x against a 9.8x consumer average. Pet is the one category nobody should quote for 2026 — Capstone's October 2025 edition reported 14.5x across 2022-YTD and the April 2026 edition publishes no multiple. At $8M in a branded better-for-you category, treat 9x as the floor.

My EBITDA looks thin after trade spend — will that hurt my valuation?

Only if you cannot rebuild it credibly, which is a documentation problem before it is a valuation problem. Buyers reconstruct your gross-to-net bridge line by line — slotting, promotional allowances, distributor deductions, returns, freight — then decide which add-backs survive. Cadent Consulting Group's 2024 study put consumer packaged goods marketing spending at 19.5% of sales, up 1.7 points since 2022, but read it precisely: that is trade promotion plus consumer promotion plus advertising, not trade spend alone. What separates a defended margin from a discounted one is whether your scanner data reconciles to your shipped profit and loss. In your Peony data room, page-level analytics show which bidder spent forty minutes on that schedule — the one preparing to retrade you — a read a shared Drive folder or an emailed PDF does not give you at all.

Strategic acquirer or consumer private equity — who actually pays more for a brand like mine?

In 2025, private equity did, which inverts what most founders are told. Capstone Partners' April 2026 report puts the median paid by financial buyers at 10.4x against 8.6x for strategics, a 1.8-turn spread on our arithmetic. Capstone's reasons are about pressure: sponsors faced elevated limited-partner pressure to deploy and competed for a narrow set of safe growth assets, while strategics self-selected into lower-multiple deals because of competing capital uses and synergy-realization sensitivity. That is not a reason to skip strategics — food M&A is still about 65% strategic, and on the right asset a strategic with a distribution thesis pays the most anyone will. It means a strategics-only process ignores a third of your buyer universe.

How do I tell whether the strategic's inbound is a real offer or just category intelligence gathering?

Watch what they sign, who they staff and what they pay for, not what they say. A serious buyer signs your non-disclosure agreement without negotiating it into uselessness, names a deal lead and a corporate development analyst, asks for a management meeting on a specific date, and engages outside counsel or a quality-of-earnings provider at their own cost. The structural defence is staged disclosure: formulations, co-manufacturer terms and retailer-level velocity stay back until a written indication of value you believe. Peony's per-viewer watermarks put the reader's identity on every rendered page, which a shared Google Drive folder does not offer.

How do I run a confidential sale process without our retailers or our co-manufacturer finding out?

By scoping access per party and staging what each one can read, rather than sending one file set to everyone. The risk here is concrete: your likeliest acquirer shares your aisle, and a rumour reaching a category manager can delay a line review or freeze a promotional plan — which then shows up as softening velocity in the exact scan data your buyers are underwriting. Your co-manufacturer is the second exposure, because a co-packer who learns you are selling can reprice a renewal or turn a routine assignment into a consent negotiation on your timetable. Practically: a separate data room per buyer, every room gated behind a signed non-disclosure agreement, formulations and retailer-level velocity in the last tranche, and access revoked the moment a conversation ends. Peony runs all of that on one plan — Advanced NDA gating with a countersigned PDF on Data Room, one-click revoke on Business and up — where a shared Drive folder offers no signed-NDA gate at all.

What should the data room look like when the most likely buyer is a competitor in my own aisle?

Separate rooms per buyer, staged tranches, and identity on every page. For a $60M-revenue brand running six to twelve buyers where several share your shelf: one Peony data room per bidder, so no party sees another's tranche, activity or Q&A; an early tranche of teaser and topline financials; a middle tranche of the gross-to-net bridge and customer economics; and a last tranche holding formulations, specifications, co-manufacturer terms and velocity by retailer, released only after a bid you believe. Peony's per-viewer dynamic watermarking burns the reader's identity into every rendered page, so a leaked formulation summary traces to one party — something a shared Google Drive folder does not offer and an emailed PDF does not carry. The Data Room plan is $52 per admin per month billed annually with unlimited free viewers, so a long buyer list costs nothing per head. Peony serves 6,800+ customers and is not an adviser.

Will a non-assignable co-manufacturer agreement kill my deal?

Rarely, and the premise is usually backwards. Under UCC section 2-210, contract rights are assignable by default unless the assignment would materially change the other party's duty, materially increase their burden or risk, or materially impair their chance of return performance — and a bare prohibition on assigning the contract is generally read as barring only delegation of performance. So whether your co-packing agreement survives a change of control is a drafting question you answer by reading your actual contract, not a market norm. What is sourced is that structure moves price: Auxo Capital Advisors' 2026 guide names co-manufacturing risk as a valuation drag. Fix assignability before you go to market, not during exclusivity, when your co-packer has leverage it did not have.

What do consumer products M&A advisers charge on a sub-$100M sale?

A monthly retainer plus a contingent success fee, with the success fee in the low-to-mid single-digit percent of enterprise value on a lower-middle-market consumer sale. The retainer is usually credited against the success fee at close. The original Lehman formula is obsolete here; the modern version is double Lehman — roughly 10% of the first $1M of value, 8% of the second, 6% of the third, 4% of the fourth and 2% thereafter — or a negotiated flat percentage with a stated minimum. The rate falls as size rises, and the proxies prove it: Goldman Sachs earned about 0.26% of enterprise value on the $35.9B Mars/Kellanova deal against up to 0.71% on the $3.1B Ferrero/WK Kellogg deal. Be sceptical of precise industry bands — the only recurring US study, the Firmex M&A Fee Guide covering 212 advisers, keeps its fee tables behind a form.

Is a banker's success fee worth it when a strategic has already approached us?

Usually yes, and the arithmetic is not close at your size. On $8M of adjusted EBITDA, a direct uncontested negotiation with one strategic anchors near the 8.6x 2025 strategic median, about $68.8M. A process that genuinely puts sponsors in the room reaches toward the 10.4x sponsor median, about $83.2M. Net that roughly $14.4M spread against a low-to-mid single-digit success fee on the higher number, call it $1.7M to $3.3M, plus a sell-side quality-of-earnings engagement, and you are ahead by well over $10M. Treat it as illustrative rather than a forecast: it assumes a second credible bidder exists and that growth holds through a six-to-nine-month process.

Sources

Where a source's exact article URL was not captured in our primary-source pass, it is cited by document identifier instead of an invented link.

Market data and multiples

• Capstone Partners, "Annual Consumer M&A Report — Middle Market Deal Activity and 2026 Outlook" (April 27, 2026) — 9.2x 2025 median EV/EBITDA vs 9.6x 2024 and a 10.5x 2016-2025 median; volume −18.9%; large deals above $250M at 30.6% of disclosed deals; PE 10.4x vs strategic 8.6x and Capstone's stated reasons; 39% of US PE companies held 4+ years, 972 exits in 2025, 7+ years to clear. https://www.capstonepartners.com/insights/
• Capstone Partners, "Food M&A Update" (April 30, 2026) — food averages 15.4x (2023), 14.9x (2024), 12.3x (2025), 12.7x (YTD 2026); volume 40 vs 24 YTD (+66.7%); branded 77.5% of volume, +210%; food 65% strategic; better-for-you 69.2% of strategic and 85.7% of PE food targets; nine-segment public comps as of 03/03/2026; McCormick / Unilever Foods at $44.8B, 3.6x revenue, 13.8x EBITDA. https://www.capstonepartners.com/insights/
• Capstone Partners, "Beverage Sector M&A Update" (March 17, 2026) — beverage 12.2x average across 2024-2025; 178 deals, −18.3%; 84.3% strategic; non-alcoholic 13.2x vs alcoholic 9.3x; JDE Peet's at $22.9B EV and 16.6x; Alani Nu at $1,885.8M EV, 3.2x revenue, 13.8x EBITDA; BeatBox at $576.5M. https://www.capstonepartners.com/insights/
• Capstone Partners, "Beauty M&A Update" (December 4, 2025) — beauty 14.9x vs a 9.8x consumer average; 56 deals, −6.7% against a consumer industry down 24.2%; public-buyer share 29.1% (2018-2023), 9% (2024), 16.1% (YTD 2025); L'Oréal's six buy-side transactions and one divestment. https://www.capstonepartners.com/insights/article-beauty-ma-update/
• Capstone Partners, "Pet Sector M&A Update," October 2025 edition — the 14.5x average across 2022-YTD, read from the archived snapshot because the live URL now serves a later edition. http://web.archive.org/web/20260310183659/https://www.capstonepartners.com/insights/article-pet-sector-ma-update/
• Capstone Partners, "Pet Sector M&A Update," current April 2026 edition — publishes no EV/EBITDA multiple at all. https://www.capstonepartners.com/insights/article-pet-sector-ma-update/
• Windsor Drake, "Lower Mid-Market Valuation EBITDA Multiples 2025" — branded CPG food and beverage at 6.8x ($1M-$3M EBITDA) and 8.1x ($3M-$5M EBITDA). https://windsordrake.com/wp-content/uploads/2025/06/Lower-Mid-Market_valuation-EBITDA-Multiples-2025.pdf
• Auxo Capital Advisors, "Food & Beverage Valuation Multiples: 2026 Guide" (last updated July 6, 2026) — subcategory ranges of roughly 6.0x-12.0x; named valuation drags including co-manufacturing risk; the 8.0x-9.0x worked example. https://auxocapitaladvisors.com/food-beverage-valuation-multiples-2025/

Deal filings and company releases

• Flowers Foods 8-K Ex-99.1 (January 2025) — $795M, $240M of 2024 net sales at 14% growth, and the full adviser roster naming Piper Sandler and Centerview for Simple Mills and RBC for Flowers. https://www.sec.gov/Archives/edgar/data/1128928/000119312525003212/d923020dex991.htm
• Vita Coco 8-K Ex-99.1 (July 2026) — $175M upfront, earnout with a $45M floor and $100M cap, Copra's 48% three-year net sales CAGR, and the Whipstitch and Evercore roster. https://www.sec.gov/Archives/edgar/data/1482981/000148298126000167/exhibit991-copra_pressrele.htm
• Celsius Holdings 8-K Ex-99.1 (February 2025) — net purchase price of $1.65B described as less than 3x 2024A net revenue and approximately 12x fully synergized 2024A EBITDA; J.P. Morgan for Alani Nu; UBS exclusive for Celsius plus the $900M term loan B and $100M revolver. https://www.sec.gov/Archives/edgar/data/1341766/000134176625000018/a991pressreleasedatedfebru.htm
• e.l.f. Beauty 8-K Ex-99.1 (May 2025) — $800M at closing plus up to $200M earnout; J.P. Morgan and Moelis for rhode; Latham & Watkins as e.l.f.'s only named adviser. https://www.sec.gov/Archives/edgar/data/1600033/000160003325000013/er991glazemasterpressrelea.htm
• e.l.f. Beauty 10-Q, quarter ended December 31, 2025 — rhode purchase-price allocation of $897.5M. https://www.sec.gov/Archives/edgar/data/1600033/000160003326000007/elf-20251231.htm
• WK Kellogg Co 8-K Ex-99.1 (July 2025) — $3.1B, $23.00 per share; Goldman Sachs and Morgan Stanley sell-side; Lazard lead and BofA co-adviser for Ferrero. https://www.sec.gov/Archives/edgar/data/1959348/000119312525157425/d72421dex991.htm
• Kellanova 8-K Ex-99.4 (August 2024) — ~$35.9B, $83.50 per share; Goldman Sachs to the company, Lazard to the Board, Citi to Mars. https://www.sec.gov/Archives/edgar/data/55067/000119312524200233/d884455dex994.htm
• Kimberly-Clark 8-K Ex-99.1 (November 2025) — ~$48.7B enterprise value, ~14.3x LTM adjusted EBITDA (8.8x post-synergy), $2.1B of run-rate synergies, and the full adviser roster. https://www.sec.gov/Archives/edgar/data/55785/000110465925105220/tm2530027d1_ex99-1.htm
• Kimberly-Clark Q2 2026 earnings 8-K Ex-99.1 (August 4, 2026) — the "remains on track to close by the end of this year" statement on Kenvue. https://www.sec.gov/Archives/edgar/data/55785/000162828026052113/kmbq22026ex-991.htm
• Keurig Dr Pepper 8-K Ex-99.1 (August 2025) — ~$18.4B for JDE Peet's; BofA exclusive sell-side; Lazard and Morgan Stanley buy-side with Morgan Stanley affiliates and MUFG providing financing. https://www.sec.gov/Archives/edgar/data/1418135/000095014225002257/eh250670939_ex9901.htm
• General Mills 8-K Ex-99 (September 2024) — North America yogurt divestiture to Lactalis and Sodiaal, J.P. Morgan exclusive. https://www.sec.gov/Archives/edgar/data/40704/000119312524220459/d804768dex99.htm
• Prestige Consumer Healthcare 8-K Ex-99.2 (2026) — the $1.045B Breathe Right, Dimetapp and Anbesol portfolio, ~$200M revenue and ~$95M EBITDA to December 31, 2025, ~11.0x EBITDA, Citi exclusive on the buy side. https://www.sec.gov/Archives/edgar/data/1295947/000110465926032332/tm269430d1_ex99-2.htm
• Utz Brands 8-K Ex-99.1 (July 21, 2026) — $14.25 per share, ~$2.9B EV, ~91% premium, expected close in Q4 2026, and the Citi, RBC, BofA and Sageworth roster. https://www.sec.gov/Archives/edgar/data/1739566/000119312526309592/d157266dex991.htm
• Insignia Capital Group, "Insignia Capital Group Completes the Sale of Portfolio Company Tillamook Country Smoker to Second Nature Brands" (August 10, 2026) — names Houlihan Lokey as exclusive financial adviser to Tillamook Country Smoker and Insignia Capital Group, with Kirkland & Ellis as legal counsel, and Solomon Partners as financial adviser to Second Nature Brands with Willkie Farr & Gallagher as its counsel. https://www.prnewswire.com/news-releases/insignia-capital-group-completes-the-sale-of-portfolio-company-tillamook-country-smoker-to-second-nature-brands-302845536.html
• Second Nature Brands, "Second Nature Brands Acquires Tillamook Country Smoker" (June 8, 2026) — the announcement date for the same transaction. https://www.prnewswire.com/news-releases/second-nature-brands-acquires-tillamook-country-smoker-302794110.html
• PepsiCo completion release on poppi (May 19, 2025) — $1.95B including approximately $300M of anticipated cash tax benefits. https://www.pepsico.com/newsroom/press-releases/2025/pepsico-completes-acquisition-of-poppi-accelerating-strategic-portfolio-transformation
• Lazard Q1 2025 earnings release, filed on Form 8-K April 25, 2025 — Siete Foods to PepsiCo at $1.2B, with the client name italicized per Lazard's stated convention. https://www.sec.gov/Archives/edgar/data/1311370/000162828025019784/laz2025q1pr.htm
• Hershey 2026 Investor Day 8-K Ex-99.1 (March 31, 2026) — the acquired-brand growth strategy. https://www.sec.gov/Archives/edgar/data/47111/000162828026022272/exhibit991-pressreleasedat.htm

Adviser fees, concentration and regulation

• Kellanova DEFM14A, filed September 26, 2024 — Goldman Sachs' approximately $93.2M transaction fee ($5M on announcement); Lazard's $10M fee ($2M on the fairness opinion).
• WK Kellogg Co DEFM14A, filed August 19, 2025 — Goldman Sachs' $2M on execution plus an $18M-$20M contingent transaction fee; Morgan Stanley on an identical structure.
• Whole Earth Brands / Ozark Holdings DEFM14A, filed June 24, 2024 — Jefferies' fee estimated at approximately $10M, $1M payable on delivery of the opinion.
• Firmex, "M&A Fee Guide 2024-2025, US Edition," with Axial and Divestopedia, based on 212 US M&A advisers — the eighth annual edition; fee tables are gated, ungated findings only.
• Celsius Holdings FY2025 Form 10-K (filed March 2, 2026) — Pepsi 43.2% and Costco 10.8% of revenue.
• e.l.f. Beauty Form 10-K for the year ended March 31, 2026 (filed May 21, 2026) — Target 18%, Walmart 13%, Amazon 11%, Sephora 10% of net sales.
• Freshpet FY2025 Form 10-K (filed February 23, 2026) — Walmart 25%, Costco 10%, top ten customers 68.0%.
• Vita Coco FY2025 Form 10-K (filed February 18, 2026) — two customers approximately 44% of consolidated net sales.
• SEC Release Nos. 33-10825; 34-89670, "Modernization of Regulation S-K Items 101, 103, and 105," effective November 9, 2020 — Item 101(c) made principles-based, with no numeric customer threshold; the prescriptive language survives only at Item 101(h)(4)(vi) for smaller reporting companies. See also 17 CFR § 229.101(c)(1)(i).
• 15 U.S.C. § 78o(b)(13) — the M&A-broker registration exemption; EBITDA under $25M or gross revenues under $250M, either limb; first inflation adjustment due December 29, 2027. https://www.law.cornell.edu/uscode/text/15/78o
• UCC § 2-210 — assignment of rights and delegation of performance in contracts for the sale of goods. https://www.law.cornell.edu/ucc/2/2-210
• "Revised Jurisdictional Thresholds for Section 7A of the Clayton Act," 91 FR 2133, published January 16, 2026 (FR document 2026-00877), effective February 17, 2026 — the $133.9M reporting floor and the 2026 filing-fee schedule starting at $35,000.

Scanner data, trade spend and market commentary

• Circana, Liquid Data Go CPG Dictionary, "Velocity" — sales per store, per TDP, or per million ACV; the $150 per store per week grocery example. https://www.circana.com/liquid-data-go/cpg-dictionary/velocity
• Circana, Liquid Data Go CPG Dictionary, "All Commodity Volume (ACV)" — ACV as a store-importance weight, with the $900,000,000 market example.
• SPINS, CPG Learning Center glossary, "Velocity" — Sales ÷ Distribution, with the $100 and $120 per store per week worked example. https://www.spins.com/cpg-learning-center/glossary/velocity/
• SPINS, CPG Learning Center glossary, "Average %ACV" — the 51.25% worked example and the Max %ACV definition. https://www.spins.com/cpg-learning-center/glossary/average-acv/
• Cadent Consulting Group, "2024 Marketing Spending Study — Finding Solid Ground with CPG Under Pressure" (September 23, 2024) — CPG marketing spending up 1.7 points since 2022 to 19.5% of sales, comprising trade promotion, consumer promotion and advertising.
• Food Dive, "Mondelēz CEO says M&A is harder as acquisition targets become 'too expensive'" (March 3, 2026).
• Beverage-Digest, "Poppi Sales Fell in 2026" (August 5, 2026).
• Financial Times — the reported approximately $1.5B Unilever / Dr. Squatch price (June 2025); Unilever's own release states no price.
• The Wall Street Journal — the $750M Hershey / LesserEvil price (April 3, 2025) and Sazerac's rejected approach to Brown-Forman (May 12, 2026), with further rejections reported through September 4, 2026.
• Reuters and The Wall Street Journal — Danone / Huel at approximately €1B, cleared by the UK Competition and Markets Authority on August 21, 2026.
• National Law Review, "FTC's New Litigation Strategy Sticks: Court Blocks Henkel's $725M Bid for Liquid Nails" (August 24, 2026).

Firm pages

• Piper Sandler consumer practice — eight verticals, 240+ consumer transactions over five years, 70+ professionals, the Stamford Partners acquisition of June 2022, and the Potbelly, Philz Coffee and EoS Fitness credits. https://www.pipersandler.com/consumer
• Whipstitch Capital — the Chocolove, Hodo, Willamette Valley Pie and Presence Marketing tombstones, the founder-led self-description, the 170+ team transactions since 2004, and the BFY Securities, LLC broker-dealer disclosure. https://whipstitchcapital.com/our-take/whipstitch-capital-serves-as-exclusive-financial-advisor-to-presence-marketing-in-strategic-sale-to-pltfrm/
• William Blair consumer and retail — the Suja Life and Once Upon a Farm IPOs, Ortholite, Better Being, Thibaut, VIP Petcare and DecoPac. https://www.williamblair.com/Investment-Banking/Consumer-and-Retail
• Harris Williams consumer industry group — Woof, California Olive Ranch, Vesta Foodservice, Brothers International, Beaba Suavinex and DecoPac, all undated. https://www.harriswilliams.com/industries/consumer
• Solomon Partners consumer and retail — the "free of conflicts of interest, as we do not lend or underwrite" statement and the Second Nature Brands, Dossier, Guess?, Stance and Vera Wang credits. https://www.solomonpartners.com/industries/consumer-retail
• Solomon Partners, About — "Through our strategic relationship with Natixis, we offer clients access to global advisory services…" https://www.solomonpartners.com/about/
• Cascadia Capital consumer — Corkcicle, Badgley Mischka, Mann Lake and 4moms, with dates. https://www.cascadiacapital.com/industries/consumer/
• Arlington Capital Advisors — the Stone Distributing, Carenbauer, Tenzing, Northern Monk, Bill's Distributing and Finnish Long Drink credits, and the Arlington Capital Services, LLC disclosure. https://arlingtoncapitaladvisors.com
• Hyde Park Capital — the No Cow and Good Karma Foods exclusive-adviser tombstone and the Axial Advisor 100 for 2026 recognition. https://hydeparkcapital.com/transactions/no-cow-good-karma-foods-acquired-by-trek-one-capital/
• Houlihan Lokey consumer industries hub and conference pages — sitemap-level only; hl.com blocks automated retrieval, and the firm's FY2026 Form 10-K names no industry groups. https://www.hl.com/industries/consumer/
• SDR Ventures consumer — Imagine Baking (2024) and the SDR Capital Markets, LLC disclosure. https://sdrventures.com/industrie/consumer/
• Intrepid Investment Bankers — founded 2010 by Ed Bagdasarian, headquartered in Brentwood, Los Angeles, MUFG-owned since January 2019 (Peony house canon, carried from our Los Angeles M&A advisors guide).

About the author: Sean Yu is the co-founder of Peony, the data room platform used by 6,800+ customers across M&A, fundraising, and private-deal workflows. He works on the access-control and analytics layer that decides who — and now what — is allowed to read a confidential document. Peony is not an M&A advisor; it is the confidential room a deal process runs in. Contact: hello@peony.ink.